If you’re looking to break out of your Netflix-nightlife-repeat routine and find some fun things to do outside with friends, ...
Leerink analyst Andrew Berens upgraded Compass Therapeutics (CMPX) to Outperform from Market Perform with a price target of $6, up from $4, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results